Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine Industry News November 23, 2012 …
Open Access Initiative Helps Neglected Tropical Disease Drug Effort Industry News November 13, 2012 …
NIH, CDC Small Business Innovation for Medical Countermeasures Contracts + Grants November 12, 2012 …
DTRA to Advance Nanostructured Therapeutics for Chem-Bio Defense Contracts + Grants October 22, 2012 …
BARDA Exercises Contract Option on Emergent BioSolutions Anthrax Vaccine Contracts + Grants October 15, 2012 …
NIH Awards $1.8M to Develop Multi-Component Malaria Vaccine Solution Industry News October 13, 2012 …
